Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Orogastric administration of crushed darunavir tablets for a critically ill patient.
Kim CH, Muzevich KM, Fulco PP. Kim CH, et al. Among authors: fulco pp. Can J Hosp Pharm. 2014 Jan;67(1):39-42. doi: 10.4212/cjhp.v67i1.1321. Can J Hosp Pharm. 2014. PMID: 24634526 Free PMC article. No abstract available.
Sustained virological response after taking crushed elvitegravir-cobicistat-emtricitabine-tenofovir tablets.
Fulco PP, Ayala-Sims VA. Fulco PP, et al. Am J Health Syst Pharm. 2014 May 15;71(10):784, 786. doi: 10.2146/ajhp130737. Am J Health Syst Pharm. 2014. PMID: 24780482 No abstract available.
Adrenal Insufficiency With Voriconazole and Inhaled/Intranasal Corticosteroids: Case Report and Systematic Review.
Duman AK, Fulco PP. Duman AK, et al. Among authors: fulco pp. J Pharm Pract. 2017 Aug;30(4):459-463. doi: 10.1177/0897190016646510. Epub 2016 May 4. J Pharm Pract. 2017. PMID: 27147607 Review.
Enteral Administration of Twice-Daily Dolutegravir and Rilpivirine as a Part of a Triple-Therapy Regimen in a Critically Ill Patient with HIV.
Turley SL, Fulco PP. Turley SL, et al. Among authors: fulco pp. J Int Assoc Provid AIDS Care. 2017 Mar/Apr;16(2):117-119. doi: 10.1177/2325957417692678. Epub 2017 Feb 15. J Int Assoc Provid AIDS Care. 2017. PMID: 28198203
Successful use of once-daily high-dose darunavir and dolutegravir in multidrug-resistant HIV.
Fulco PP, Leibrand Kaczmar CR, Gomes D, Smith T. Fulco PP, et al. J Clin Pharm Ther. 2020 Apr;45(2):394-396. doi: 10.1111/jcpt.13081. Epub 2019 Nov 25. J Clin Pharm Ther. 2020. PMID: 31765502
Administration of crushed ledipasvir-sofosbuvir tablets via gastrostomy button in a patient coinfected with HIV and hepatitis C virus.
Fulco PP, Sterling RK, Lavoie SR. Fulco PP, et al. Am J Health Syst Pharm. 2017 Nov 1;74(21):1761-1762. doi: 10.2146/ajhp170452. Am J Health Syst Pharm. 2017. PMID: 29070496 No abstract available.
Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent.
Fulco P, Wenzel RP. Fulco P, et al. Expert Rev Anti Infect Ther. 2006 Dec;4(6):939-45. doi: 10.1586/14787210.4.6.939. Expert Rev Anti Infect Ther. 2006. PMID: 17181409 Review.
Possible antiretroviral therapy-warfarin drug interaction.
Fulco PP, Zingone MM, Higginson RT. Fulco PP, et al. Pharmacotherapy. 2008 Jul;28(7):945-9. doi: 10.1592/phco.28.7.945. Pharmacotherapy. 2008. PMID: 18576910
Etravirine and rilpivirine: nonnucleoside reverse transcriptase inhibitors with activity against human immunodeficiency virus type 1 strains resistant to previous nonnucleoside agents.
Fulco PP, McNicholl IR. Fulco PP, et al. Pharmacotherapy. 2009 Mar;29(3):281-94. doi: 10.1592/phco.29.3.281. Pharmacotherapy. 2009. PMID: 19249947 Review.
Raltegravir dosage adjustment in HIV-infected patients receiving etravirine.
Do VT, Higginson RT, Fulco PP. Do VT, et al. Among authors: fulco pp. Am J Health Syst Pharm. 2011 Nov 1;68(21):2049-54. doi: 10.2146/ajhp110083. Am J Health Syst Pharm. 2011. PMID: 22011983
30 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback